The device developed by researchers from University in Tarragona (URV) in Spain counts the number of tumour cells in a blood sample in real time and is thus a highly effective tool for improving the monitoring, treatment and diagnosis of cancer.
The device can accurately determine a patient's level of health and monitors cancer quickly, cheaply, effectively and non-invasively, researchers said.
Furthermore, it can assist in the early diagnosis of the disease and monitor tumours more effectively and in a manner that has a less negative effect on patients' bodies.
The ratio between the two reveals how the cancer is progressing.
The finding were published in the journal Scientific Reports.